Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of hyperthermia on cisplatin tissue penetration and gene expression in peritoneal metastases: results from a randomized trial in ovarian cancer.
Demuytere J, Carlier C, Van Helden T, Belza J, Vanhaecke F, Xie F, Vermeulen A, Weerts J, Thomale J, Denys H, Tummers P, Van Kerschaver O, Willaert W, Cosyns S, Merseburger P, Claeys A, Van den Eynden J, Ceelen W. Demuytere J, et al. Among authors: carlier c. Br J Surg. 2024 Apr 3;111(4):znae078. doi: 10.1093/bjs/znae078. Br J Surg. 2024. PMID: 38656960 Clinical Trial. No abstract available.
Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine Xenografts.
Demuytere J, Carlier C, Van de Sande L, Hoorens A, De Clercq K, Giordano S, Morosi L, Matteo C, Zucchetti M, Davoli E, Van Dorpe J, Vervaet C, Ceelen W. Demuytere J, et al. Among authors: carlier c. Int J Nanomedicine. 2024 Jan 17;19:429-440. doi: 10.2147/IJN.S424045. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38260242 Free PMC article.
Prevalence of cannabidiol (CBD) consumption and cancer patients' expectations in one oncology day-hospital: A cross-sectional study and questionnaire validation.
Le Bozec A, Guédon M, Brugel M, Laurent M, Carlier C, Hettler D, Perrier M, Aubert L, Slimano F, Mongaret C, Bouché O. Le Bozec A, et al. Among authors: carlier c. J Oncol Pharm Pract. 2023 Jul 12:10781552231187136. doi: 10.1177/10781552231187136. Online ahead of print. J Oncol Pharm Pract. 2023. PMID: 37437182
Genetic counselling referral practices for patients with pancreatic adenocarcinoma: A French retrospective multicentre observational cohort study (CAPANCOGEN).
Brugel M, Marulier T, Evrard C, Carlier C, Tougeron D, Piessen G, Truant S, Turpin A, Williet N, Botsen D, Brasseur M, Perrier M, Bouché O. Brugel M, et al. Among authors: carlier c. Pancreatology. 2023 Sep;23(6):622-629. doi: 10.1016/j.pan.2023.06.010. Epub 2023 Jun 19. Pancreatology. 2023. PMID: 37394294
Renal impairment and abnormal liver function tests in pre-therapeutic phenotype-based DPD deficiency screening using uracilemia: a comprehensive population-based study in 1138 patients.
Callon S, Brugel M, Botsen D, Royer B, Slimano F, Feliu C, Gozalo C, Konecki C, Devie B, Carlier C, Daire V, Laurés N, Perrier M, Djerada Z, Bouché O. Callon S, et al. Among authors: carlier c. Ther Adv Med Oncol. 2023 Jan 10;15:17588359221148536. doi: 10.1177/17588359221148536. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 36643657 Free PMC article.
178 results